Glickman Urological & Kidney Institute Outcomes
Surgical Quality Improvement
Nephrectomy Outcomes
Nephrectomy ACS NSQIP Outcomes
January 1, 2024 – December 31, 2024
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s nephrectomy ACS NSQIP performance benchmarked against 133 participating sites.
| Nephrectomy (133 Sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Mortality | 150 | 2.00% | 0.43% |
| 30 Day Morbidity | 150 | 9.33% | 9.23% |
| Cardiac | 150 | 1.33% | 0.45% |
| Pneumonia | 149 | 0.00% | 1.54% |
| Ventilator > 48 Hours | 150 | 2.00% | 0.44% |
| Deep Vein Thrombosis (DVT) / Pulmonary Embolus | 150 | 0.00% | 1.10% |
| Renal Failure | 150 | 5.33% | 2.03% |
| Surgical Site Infection (SSI) | 149 | 3.36% | 3.22% |
| Sepsis | 150 | 1.33% | 1.27% |
| C.diff Colitis | 150 | 0.00% | 0.12% |
| Length of Stayᵃ | 135 | 27.41% | 17.42% |
| Prolonged NPO/NGT Use | 150 | 3.33% | 2.81% |
| Urinary Leak/Fistula | 150 | 0.67% | 0.74% |
| Lymphocele/Leak/Fluid | 150 | 0.00% | 1.80% |
American College of Surgeons National Surgical Quality Improvement Program, 2025.
ACS NSQIP® Semiannual Report July, 2025, Chicago: American College of Surgeons.
ᵃIdentified as a statistical outlier (higher than expected) by the ACS NSQIP hierarchical model.
